Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $1.81 Million - $3.02 Million
48,200 New
48,200 $3.02 Million
Q1 2020

May 15, 2020

SELL
$17.27 - $40.17 $932,580 - $2.17 Million
-54,000 Closed
0 $0
Q4 2019

Feb 12, 2021

BUY
$32.1 - $40.4 $1.72 Million - $2.16 Million
53,460 Added 9900.0%
54,000 $1.82 Million
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $17,334 - $21,816
540 New
540 $10,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.